Holen Sie sich die Stockscreener-App
2.61
1.56%
0.04
Finanzdaten der Lipella Pharmaceuticals Inc-Aktie (LIPO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.1459
|
- | - | - | 0.118 |
Operating Expenses
|
1.3635
|
- | - | - | 1.2025 |
| Benefits Costs and Expenses |
1.3377
|
- | - | - | 1.1859 |
| Costs And Expenses |
1.3377
|
- | - | - | 1.1859 |
| Operating Income/Loss |
66.89%
-1.2176
|
-0.7296 | -1.3567 | -1.5752 | -1.0844 |
| Nonoperating Income/Loss |
36.53%
0.0258
|
0.0407 | 0.0332 | 0.0365 | 0.0166 |
| Income/Loss From Continuing Operations Before Tax |
73.01%
-1.1918
|
-0.6889 | -1.3236 | -1.5387 | -1.0678 |
| Income/Loss From Continuing Operations After Tax |
73.01%
-1.1918
|
-0.6889 | -1.3236 | -1.5387 | -1.0678 |
|
Net Income/Loss
|
73.01%
-1.1918
|
-0.6889 | -1.3236 | -1.5387 | -1.0678 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,750%
7.2924
|
0.2558 | 5.7537 | 5.7439 | 5.7439 |
| Diluted Average Shares |
2,750%
7.2924
|
0.2558 | 5.7537 | 5.7439 | 5.7439 |
| Basic Earnings Per Share |
77.78%
-0.16
|
-0.09 | -0.23 | -0.27 | -0.19 |
| Diluted Earnings Per Share |
77.78%
-0.16
|
-0.09 | -0.23 | -0.27 | -0.19 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):